北京 [切换城市] 北京招聘北京生物/制药/医疗器械招聘北京生物工程/生物制药招聘

Associate Global Medical Safety Officer

天境生物科技(上海)有限公司

  • 公司规模:150-500人
  • 公司性质:合资
  • 公司行业:医疗/护理/卫生

职位信息

  • 发布日期:2019-09-29
  • 工作地点:上海
  • 招聘人数:1人
  • 工作经验:3-4年经验
  • 学历要求:硕士
  • 职位月薪:3-4万/月
  • 职位类别:生物工程/生物制药

职位描述

Major Responsibilities and Duties:

Supporting Global MSO for below activities:

  1. Provide safety leadership for Clinical Development including Clinical Study,
    Investigator Sponsored, Compassionate Use, and other Programs; liaise
    with Clinical Development, Clinical Operations, Medical Affairs.
  2. Biometrics, Regulatory Affairs, CROs, Data Monitoring Committees (DMCs)
    and other entities to contribute to overall study execution while
    ensuring safety strategy and operational excellence.
  3. Provide safety leadership to Commercial organization to support global launch
    activities for assigned products if applicable.
  4. Responsible for the preparation and review of safety-related section(s) for clinical,
    regulatory, and scientific documents including protocols, informed
    consent forms, case report forms (CRFs), statistical plans, clinical
    study reports/synopses, integrated summaries of safety, New Drug or
    Biologic License Applications (NDA/BLA), Marketing Authorization Applications
    (MAA), Common Technical Document (CTD) submissions, Regulatory Agency
    responses, IRB/EC requests, briefing books, manuscripts/journal articles
    and other documents as needed, ensuring safety profile reflected for
    assigned products.
  5. Responsible for the creation and maintenance of Company Core Safety Information (CCSI) and
    ensure implementation of CCSI in all Reference Safety Information (RSI)
    including Investigator Brochures (IBs), Company Core Data Sheet (CCDS),
    national labels and other associated product labeling.
  6. Responsible for signal detection activities to ensure signal identification, evaluation,
    validation, for assigned products including individual and aggregate
    data analyses; interpretation of safety signals and trends;
    documentation and communication of safety assessments (written and
    verbal) of safety risks in collaboration with key internal/external
    stakeholders.
  7. Chair and/or co-chair on Safety Management Team (SMT), Product Benefit Risk Committee (PBRC), and
    other executive forums for assigned products.
  8. Contribute to the preparation of pre- and post- marketing aggregate safety reports
    including Periodic Safety Update Reports (PSURs)/Periodic Benefit Risk
    Evaluation Reports (PBRERs), Periodic Adverse Drug Experience Reports
    (PADERs), Development Safety Update Reports (DSURs), IND Annual Reports,
    and 6-monthly Suspected Unexpected Serious Adverse Reactions (SUSARs)
    Line Listing Reports and ensure consistent communication of safety
    profile/topics across various regulatory safety documents for assigned
    products.
  9. Lead risk-benefit evaluations and contribute to preparation of Risk Management/Control
    Plans (RMPs/RCPs) for assigned products ensuring identification of
    risks, appropriate risk minimization and effectiveness measures in
    accord with regulatory requirements.
  10. Provide medical review of individual case safety reports (clinical and spontaneous) and all
    safety analyses, to ensure accurate coding, seriousness, expectedness
    and company causality assessment, appropriate medical interpretation,
    consistency in case assessment and accurate reporting to Health
    Authorities, Ethics Committees, and business partners.
  11. Develop or support to the development of I-Mab or department processes including policies,
    Standard Operating Procedures and other relevant safety documentation
    (eg. Safety Management Plans, data entry guidelines, etc.)
  12. Support inspection readiness activities, internal audits and external inspections.
  13. Participate in the PV vendor selection activities and contribute to vendor governance
    activities and key performance indicators to ensure safety operation excellence
    contribute to the generation of Pharmacovigilance
    Agreements (PVAs) or Safety Data Exchange Agreements (SDEAs).
  14. Provide safety expertise to due diligence activities as needed.
  15. Keeps abreast of new PV/safety regulations and guidance from the regulatory authorities.
  16. Mentor junior medical office staff; develop and provide training within specific areas of
    knowledge.

Qualifications:


  1. MD required; clinical research and/or fellowship training in oncology, immunology, genetics, pediatrics,
    pharmacology or other relevant specialty is a plus.
  2. Minimum 2-4 years Drug Safety/Pharmacovigilance experience plus 2 years clinical development
    experience; other relevant experience may be considered.
  3. Excellent understanding of global PV regulatory environment with working knowledge of international
    regulations, initiatives, standards and Good Pharmacovigilance practices
    (GVP) including but not limited to China, Americas, European Union and
    Asia-Pacific territories including a thorough understanding of case
    processing and other pharmacovigilance processes. Exposure to working
    relationship with the NMPA, FDA and other regulatory authorities is
    preferred.
  4. Ability to manage multiple tasks with deadlines in fast-paced working environment with demonstrated successful
    management of complex projects within the scope of this position
  5. Must have excellent written and oral communication skills, resourcefulness and personal organization skills
    together with demonstrated cross-functional teamwork.
  6. Some national/international travel may be required.


职能类别:生物工程/生物制药

公司介绍

天境生物科技(上海)有限公司
天境生物由臧敬五博士领衔的创新药资深研发团队创建,是一家聚焦在肿瘤免疫和自身免疫疾病精准医疗领域的新药研发生物医药科技公司。
公司的核心竞争力在于早期研发、靶点发现和验证、工艺开发&临床前评价、质量科学&质量管理、早期临床研究的能力(包括临床一期和临床二期)。团队在创新药物靶点生物学、创新抗体药物分子结构研发以及创新药物的转化医学及临床研究方面的优势为公司建立一条具有国际竞争力的项目管线创造了基础。公司目前创新药管线含12个在研创新抗体药物项目。领先的创新药项目将在2017年3月申报临床研究并在台湾, 韩国及中国启动临床研究, 其它项目均已进入细胞株或工艺开发阶段。
公司从成立以来已经建立了广泛深入的国际合作, 如与瑞士FERRING公司合作独家引进开发Olamkicept。公司自主研发的全球创新药项目将在2018年进入中国及美国临床研究申报环节并计划在两地启动一期临床研究。

联系方式

  • 公司地址:华贸写字楼3期